Related Experiment Video

Updated: Jul 15, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Reassessment of statins to retard the progression of aortic stenosis

Nalini M Rajamannan1

  • 1Department of Medicine, Northwestern University Medical School, Chicago, IL 60611, USA. n-rajamannan@northwestern.edu

Current Cardiology Reports
|April 14, 2007
PubMed

Insights

Aortic valve stenosis may be slowed by medical therapies targeting atherosclerosis risk factors. Current research is exploring this potential, with ongoing studies examining long-term outcomes.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Atherosclerosis Research

Background:

  • Aortic valve stenosis is a leading cause for surgical valve replacement in the US and Europe.
  • Historically viewed as a degenerative condition, valvular heart disease now shows links to atherosclerosis.
  • Shared risk factors suggest potential for medical intervention in valvular heart disease.

Purpose of the Study:

  • To review clinical studies on the role of medical therapy in managing aortic valve stenosis.
  • To explore the potential of targeting atherosclerosis risk factors to slow valvular heart disease progression.

Main Methods:

  • Review of retrospective and prospective clinical studies.
  • Analysis of research correlating atherosclerosis risk factors with valvular heart disease.
  • Synthesis of current evidence on medical therapy for aortic valve stenosis.

Main Results:

  • Retrospective studies suggest medical therapy can slow disease progression.
  • Prospective data on the efficacy of medical therapy for long-term outcomes remain conflicting.
  • Growing evidence supports the potential of medical interventions.

Conclusions:

  • Medical therapy targeting shared risk factors shows promise for slowing aortic valve stenosis.
  • Further prospective research is needed to clarify the definitive outcomes of medical management.
  • This review highlights the evolving understanding and therapeutic potential for valvular heart disease.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...